PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
20.86%
Revenue growth 1.25-1.5x ACB.TO's 14.70%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
-21.47%
Negative gross profit growth while ACB.TO is at 1.47%. Joel Greenblatt would examine cost competitiveness or demand decline.
-27.53%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-27.53%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
686.38%
Positive net income growth while ACB.TO is negative. John Neff might see a big relative performance advantage.
671.43%
Positive EPS growth while ACB.TO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
669.28%
Positive diluted EPS growth while ACB.TO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-12852.71%
Negative OCF growth while ACB.TO is at 151.02%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
5.64%
FCF growth under 50% of ACB.TO's 53.39%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1150.19%
Negative 10Y OCF/share CAGR while ACB.TO stands at 1435.91%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-1150.19%
Negative 5Y OCF/share CAGR while ACB.TO is at 259.10%. Joel Greenblatt would question the firm’s operational model or cost structure.
-11.55%
Negative 3Y OCF/share CAGR while ACB.TO stands at 976.63%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
2791.98%
Positive 10Y CAGR while ACB.TO is negative. John Neff might see a substantial advantage in bottom-line trajectory.
2791.98%
Positive 5Y CAGR while ACB.TO is negative. John Neff might view this as a strong mid-term relative advantage.
4465.63%
Positive short-term CAGR while ACB.TO is negative. John Neff would see a clear advantage in near-term profit trajectory.
1891.94%
10Y equity/share CAGR above 1.5x ACB.TO's 592.19%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
1891.94%
5Y equity/share CAGR above 1.5x ACB.TO's 1097.91%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
4563.18%
3Y equity/share CAGR above 1.5x ACB.TO's 2025.10%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
98.77%
AR growth is negative/stable vs. ACB.TO's 273.21%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
63.89%
Inventory growth well above ACB.TO's 35.63%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
11.84%
Asset growth well under 50% of ACB.TO's 63.74%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
13.20%
Under 50% of ACB.TO's 56.95%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
5.20%
Debt shrinking faster vs. ACB.TO's 240.01%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
96.49%
R&D growth drastically higher vs. ACB.TO's 136.39%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
97.59%
SG&A growth well above ACB.TO's 4.24%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.